Barclays
STIM icon

Barclays’s Neuronetics STIM Stock Holding History

Barclays’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$60.6K Buy
25,904
+20,065
+344% +$49.3K ﹤0.01% 4511
2026
Q2 		$7.59K Sell
5,839
-665
-10% -$968 ﹤0.01% 4734
2026
Q1 		$9.43K Sell
6,504
-55,102
-89% -$87.3K ﹤0.01% 4709
2025
Q4 		$85K Buy
61,606
+9,941
+19% +$20.8K ﹤0.01% 4623
2025
Q3 		$141K Sell
51,665
-11,715
-18% -$41.6K ﹤0.01% 4513
2025
Q2 		$221K Buy
+63,380
New +$250K ﹤0.01% 4210
2022
Q3 		– Sell
-94
Closed – – 5124
2022
Q2 		$0 Sell
94
-4,051
-98% -$11.8K ﹤0.01% 5252
2022
Q1 		$12K Sell
4,145
-26,827
-87% -$90.7K ﹤0.01% 4568
2021
Q4 		$138K Buy
30,972
+20,543
+197% +$101K ﹤0.01% 3661
2021
Q3 		$69K Buy
10,429
+7,270
+230% +$69.7K ﹤0.01% 4031
2021
Q2 		$51K Sell
3,159
-1,939
-38% -$26.8K ﹤0.01% 4127
2021
Q1 		$63K Sell
5,098
-5,758
-53% -$88.3K ﹤0.01% 4157
2020
Q4 		$121K Sell
10,856
-11,723
-52% -$88.1K ﹤0.01% 4049
2020
Q3 		$110K Sell
22,579
-3,819
-14% -$14.5K ﹤0.01% 4202
2020
Q2 		$51K Buy
26,398
+21,939
+492% +$45K ﹤0.01% 4928
2020
Q1 		$9K Sell
4,459
-8,979
-67% -$28.1K ﹤0.01% 5850
2019
Q4 		$60K Buy
13,438
+6,646
+98% +$41.3K ﹤0.01% 5687
2019
Q3 		$57K Sell
6,792
-1,890
-22% -$20.6K ﹤0.01% 5850
2019
Q2 		$109K Buy
8,682
+2,543
+41% +$35.9K ﹤0.01% 5618
2019
Q1 		$94K Buy
6,139
+4,839
+372% +$80.1K ﹤0.01% 5410
2018
Q4 		$25K Sell
1,300
-1,091
-46% -$23.9K ﹤0.01% 5798
2018
Q3 		$77K Buy
+2,391
New +$72.7K ﹤0.01% 5788

Other funds holding STIM

Lane Generational
Lane Generational Dover, Massachusetts $111M AUM 16.63% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
VestGen Advisors
VestGen Advisors Inverness, Illinois $3.25B AUM 30.95% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return

Barclays's STIM Position: Q3 2026 in Review

Barclays increased its Neuronetics (STIM) stake by 344% in Q3 2026, buying an estimated $49.3K and bringing the position to 25,904 shares worth $60.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4511.

Barclays first reported a position in STIM in Q3 2018 and has held it in 22 quarters since. The position peaked at $221K in Q2 2025. 28 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • Barclays held 25,904 shares of Neuronetics worth $60.6K as of Q3 2026.
  • Barclays bought 20,065 Neuronetics shares in Q3 2026, an estimated $49.3K.
  • Neuronetics made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4511 holding.
  • Barclays first reported a position in Neuronetics in Q3 2018 and has held it in 22 quarters since.
  • Barclays's Neuronetics position peaked at $221K in Q2 2025.
  • 28 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.